Upload
anakin
View
32
Download
0
Embed Size (px)
DESCRIPTION
Notification Messaging to Support FDA. Building an HL7 Version 3 Based Approach for Disease Notification & Applying it to Drug Reaction Reporting. A Basic Premise for the Discussion. - PowerPoint PPT Presentation
Citation preview
Drug Reaction Notification 2 October 2002 - Page: 1SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Notification Messaging to Notification Messaging to Support FDASupport FDA
Building an HL7 Version 3 Based Approach for Disease Notification & Applying it to Drug Reaction Reporting
Building an HL7 Version 3 Based Approach for Disease Notification & Applying it to Drug Reaction Reporting
Drug Reaction Notification 2 October 2002 - Page: 2SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
A Basic Premise for the DiscussionA Basic Premise for the Discussion
There is a core concept that is something like “Notification”. That concept is sufficiently applicable to a wide range of public health activities, ranging from disease notification to drug reaction reporting, for the work done to support NEDSS to be relevant to FDA’s reporting needs.
There is a core concept that is something like “Notification”. That concept is sufficiently applicable to a wide range of public health activities, ranging from disease notification to drug reaction reporting, for the work done to support NEDSS to be relevant to FDA’s reporting needs.
Drug Reaction Notification 2 October 2002 - Page: 3SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Presentation ObjectivesPresentation Objectives
A little NEDSSCDC Messaging Development
Notification message contents as an example of the process
Using Notification Messaging to address FDA requirements Introduce the E2BM mappingReview mapping contents
HL7 standardization of Notification MessagingProposed next steps
A little NEDSSCDC Messaging Development
Notification message contents as an example of the process
Using Notification Messaging to address FDA requirements Introduce the E2BM mappingReview mapping contents
HL7 standardization of Notification MessagingProposed next steps
Drug Reaction Notification 2 October 2002 - Page: 4SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
A Vision for National Electronic A Vision for National Electronic Disease Surveillance System Disease Surveillance System
(NEDSS)(NEDSS)
Gathers health data automatically from a variety of sources on a real-time basis
Monitors the health of communities Assists in ongoing analyses of trends and
detection of emerging public health problems
Provides information for setting public health policies
Is a system of interoperable systems like the Internet is a network of interoperable networks
Gathers health data automatically from a variety of sources on a real-time basis
Monitors the health of communities Assists in ongoing analyses of trends and
detection of emerging public health problems
Provides information for setting public health policies
Is a system of interoperable systems like the Internet is a network of interoperable networks
Drug Reaction Notification 2 October 2002 - Page: 5SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
NEDSS & National StandardsNEDSS & National StandardsUsing
Use wherever possibleUse and publish “design specifications” in
order to do the workHave a very high bar to change vs. deriveBe prepared to follow the refinement of
standards Influencing
See that public health issues are represented in national standards
Document specification development activities
Use opportunities to promote the sometimes more difficult approach of using standards
UsingUse wherever possibleUse and publish “design specifications” in
order to do the workHave a very high bar to change vs. deriveBe prepared to follow the refinement of
standards Influencing
See that public health issues are represented in national standards
Document specification development activities
Use opportunities to promote the sometimes more difficult approach of using standards
Drug Reaction Notification 2 October 2002 - Page: 6SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Design Philosophy for CDC Design Philosophy for CDC Messaging ProjectsMessaging Projects
Develop HL7 Version 3 messages. Use the RIM and the Message Development
Framework. Use HL7 vocabulary domainsCreate a consistent set of work products across
the projects.Standardize by forwarding messages within
HL7 Influence HL7
Suggest RIM changes and vocabulary itemsPlan to submit message formats for
standardizationWork within the technical architecture
developed by NEDSS
Develop HL7 Version 3 messages. Use the RIM and the Message Development
Framework. Use HL7 vocabulary domainsCreate a consistent set of work products across
the projects.Standardize by forwarding messages within
HL7 Influence HL7
Suggest RIM changes and vocabulary itemsPlan to submit message formats for
standardizationWork within the technical architecture
developed by NEDSS
Drug Reaction Notification 2 October 2002 - Page: 7SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Using the MDF - CDC StyleUsing the MDF - CDC StyleDocument messaging requirementsMap relevant data to the RIM. Use data
mapping as a source for the R-MIM. (These two can be documented together with simple source data.)
HL7 tooling supports definition of HMDs, message types, and XML schemas.
Create mappings between message elements and source and target databases
Address vocabulary issues by looking at HL7 domains first, but not last.
Document messaging requirementsMap relevant data to the RIM. Use data
mapping as a source for the R-MIM. (These two can be documented together with simple source data.)
HL7 tooling supports definition of HMDs, message types, and XML schemas.
Create mappings between message elements and source and target databases
Address vocabulary issues by looking at HL7 domains first, but not last.
Drug Reaction Notification 2 October 2002 - Page: 8SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Current CDC ProjectsCurrent CDC ProjectsNotification Messaging
Communicate notifiable disease reports from states to CDC.
Core component of the NEDSS Base System.Vital Statistics
Provide a specification for Birth and Death information.
Also support “verification/certification”.Antimicrobial Use Reporting
Periodic (monthly) reporting of antibiotics use and organism susceptibility from providers to CDC.
Notification MessagingCommunicate notifiable disease reports from
states to CDC.Core component of the NEDSS Base System.
Vital StatisticsProvide a specification for Birth and Death
information.Also support “verification/certification”.
Antimicrobial Use ReportingPeriodic (monthly) reporting of antibiotics use
and organism susceptibility from providers to CDC.
Drug Reaction Notification 2 October 2002 - Page: 9SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
The Elements of Messaging AnalysisThe Elements of Messaging Analysis
Use Case ModelStatement of Requirements
We did not do formal use case analysis. This would be important for a “new” area.
To a certain extent, documentation for the NEDSS Base System addresses this requirement.
Use Case ModelStatement of Requirements
We did not do formal use case analysis. This would be important for a “new” area.
To a certain extent, documentation for the NEDSS Base System addresses this requirement.
Drug Reaction Notification 2 October 2002 - Page: 10SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Messaging Analysis ContinuedMessaging Analysis Continued
Interaction Model Messaging Scenarios –
This documents needs for communication, as well as the discussion around those needs.
Interaction DiagramA record of the interactions to be supported
Interaction GridDocuments Trigger events, and message dependencies.
Interaction Model Messaging Scenarios –
This documents needs for communication, as well as the discussion around those needs.
Interaction DiagramA record of the interactions to be supported
Interaction GridDocuments Trigger events, and message dependencies.
Drug Reaction Notification 2 October 2002 - Page: 11SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Notification Messaging Notification Messaging ScenariosScenarios
I. Condition NotificationState or other reporting base system sends a notification to CDC. CDC will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed.
II. Change/Retraction of Prior NotificationState or other reporting base system sends a notification update/change/retraction. This message will always provide a reference to the earlier notification that is being updated, changed, or retracted. CDC will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed.
I. Condition NotificationState or other reporting base system sends a notification to CDC. CDC will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed.
II. Change/Retraction of Prior NotificationState or other reporting base system sends a notification update/change/retraction. This message will always provide a reference to the earlier notification that is being updated, changed, or retracted. CDC will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed.
Drug Reaction Notification 2 October 2002 - Page: 12SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Notification Messaging Notification Messaging ScenariosScenarios
III. Summary NotificationState or other reporting base system provides total amounts for the reporting, during a specified time period, of a specific disease or condition to CDC. CDC will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed.
IV. Notification ResponseCDC will provide a response to the state or other reporting base system once the CDC base system has processed the message. This message will indicate that the message was successfully processed by the interface engine. The state or other reporting base system will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed
III. Summary NotificationState or other reporting base system provides total amounts for the reporting, during a specified time period, of a specific disease or condition to CDC. CDC will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed.
IV. Notification ResponseCDC will provide a response to the state or other reporting base system once the CDC base system has processed the message. This message will indicate that the message was successfully processed by the interface engine. The state or other reporting base system will acknowledge receipt. A negative acknowledgement will be sent if the message that has been received cannot be processed
Drug Reaction Notification 2 October 2002 - Page: 13SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Interaction SpecificationInteraction Specification
1: Condition Notification
Base System
CDC Base System
3: Summary Notification 4: Notification Response
2: Change/Retraction of Prior Notification
Drug Reaction Notification 2 October 2002 - Page: 14SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Diagram Based MappingDiagram Based MappingActmood: eventclass cd: notificaitontype cd: RCTTYPEtype cd: SYSVERcritical date time: YEAR,WEEKstatus code: REPSTATUS
Participationtype_cd: author
Roleclass cd:jurisdictiontype_cd reportingentity:
EntityClass cd: Placetype cd: netss stateplace name: STATE
EntityClass cd: living subjectentity id: SUBJECTIDbirth date: DOBsex cd: SEXrace cd: HISPANIC,ASIAN, BLACK, AMIND,NAHAQ, WHITE, ORACErace modf: : OTH_SPEC
Actmood:: eventClass cd: casetype cd: EVENTactivity id: REPORTIDcritidal date time:ONSETDATEclassification status cd:CASE STATUSdisease imported code:IMPORTED
Participationtype_cd: location
Roleclass cd:jurisdictiontype_cd reportingentity:
EntityClass cd: Placetype cd: netss siteentity id: SITE
Actmood:: eventclass cd: obsvobsv value: RCDCOUNT
Act_relationshiptype_cd: pertains
EntityClass cd: placetyppe cd: netss countyplace name: COUNTY
Participationtype_cd: subjecttarget
Roleclass cd:residence
Participationtype_cd: location
Roleclass cd:jurisdictiontype_cd :reporting entity
Actmood: eventclass cd: obsvtype cd: AGETYPEvalue: AGE
Actmood: eventclass cd: obsvtype cd: AGETYPEvalue: AGE CAT
Locatorclass cd: postal addresstype cd: NETSS zip codestreeet address: POSTCD
Actmood: eventclass cd: obsvtype cd:: netss educationvalue: EDUC
EntityClass cd: Entity Grouptype cd: adultgroup count: ADLTHOUSE
Roleclass cd:: grouptype cd:membership inhouushold
EntityClass cd: Entity Grouptype cd: adultgroup count: CHILDHOUS
Roleclass cd: grouptype cd:membership inhouushold
Actmood: eventclass cd: diagmpsistype cd::actv date time: DIAGDATE
Actmood: eventclass cd: HRAtype cd:: : specimen collectionactv date time: SPECDATE
Roleclass_cd :specimen
EntityClass cd: materialtype cd: SPECTYPE
Actmood: eventclass cd: notificaitontype cd: first report to publichealthactivity date time: PHDATE
Actmood: eventclass cd: notificaitontype cd: first report to CDCactivity date time:FSTMXDATE
Actmood: eventclass cd: obsvtype cd:: netss observationindiccatorvalue:: OUTBREAKIND
Actmood: eventclass cd: outbreakidentifier: OUTBREAKID
Actmood: eventclass cd: obsvtype cd:: LABTESTactivity date time: LABDATEvalue: LABRESULT
Actmood: eventclass cd: obsvtype cd:: netss outcomevalue: OUTCOME
Actmood: eventclass cd: obsvtype cd:: netsshospitilazation indicatorvalue: HOSPITAL
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Act_relationshiptype_cd: pertains
Participationtype_cd:specimen
Locator_relationshiptype_cd: case relevant
Used to discover detailed data requirements.
Can be constructed in a group session.
Becomes an education on the HL7 RIM.
Leads naturally into RMIM construction.
This is the stage we have reached with the FDA specifications.
Used to discover detailed data requirements.
Can be constructed in a group session.
Becomes an education on the HL7 RIM.
Leads naturally into RMIM construction.
This is the stage we have reached with the FDA specifications.
Drug Reaction Notification 2 October 2002 - Page: 15SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
R-MIM for NotificationR-MIM for Notification Message header to carry transactional information Identification of the notification sender and receiver Case specific information Other notifications related to the case Patient encounters associated with the case Case participants including the patient or subject of
the case and locations associated with the case. Associations between participants in the case Case related specimens and specimen collection
procedures. Observation information, such as laboratory tests,
about participants or specimens related to the case.
Message header to carry transactional information Identification of the notification sender and receiver Case specific information Other notifications related to the case Patient encounters associated with the case Case participants including the patient or subject of
the case and locations associated with the case. Associations between participants in the case Case related specimens and specimen collection
procedures. Observation information, such as laboratory tests,
about participants or specimens related to the case.
Drug Reaction Notification 2 October 2002 - Page: 16SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
R-MIM Part 1R-MIM Part 1 Diagram should contain the V3 Outer wrapper
and Controlled Act wrapper. Content determined by HL7 consistently for all
messages.
Diagram should contain the V3 Outer wrapper and Controlled Act wrapper.
Content determined by HL7 consistently for all messages.
Drug Reaction Notification 2 October 2002 - Page: 17SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
A Few CommentsA Few Comments
This section of the message will change for consistency with new HL7 developments
HL7 will offer a single structure“Outer Wrapper”: Captures the message
header & message sender and receiver. This is basic transactional information.
“Message Control Act”: A single way to model data for the “trigger event”, the event that causes data to flow.
This section of the message will change for consistency with new HL7 developments
HL7 will offer a single structure“Outer Wrapper”: Captures the message
header & message sender and receiver. This is basic transactional information.
“Message Control Act”: A single way to model data for the “trigger event”, the event that causes data to flow.
Drug Reaction Notification 2 October 2002 - Page: 18SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Notification Payload V1Notification Payload V1AR_Observation_relationship
0..*
0..*
type_cd*: CS [1..1] <= PERT
A_Case_observation
class_cd* <= OBSmood_cd*: <= EVNcd: CV [1..1]effective_time: IVL<TS> [0..1]activity_time: IVL<TS> [0..1]value: ANY [1..1]interpretation_cd: CV [0..1]method_cd: CV [0..1]
0..*
AR_Case_observationtype_cd*: <= COMP
E_Case_related_place
class_cd* <= PLCdeterminer_cd* <= INSTANCEcd: CV [1..1]id: II [0..1]nm: EN [0..1]addr: AD [0..1]
E_Case_related_person
class_cd* <= PSNdeterminer_cd* <= INSTANCEadministrative_sex_cd: CV [0..1]birth_time: TS [0..1]deceased_ind: BL [0..1]deceased_time: TS [0..1]marital_status_cd: CV [0..1]education_level_cd: CV [0..1]race_cd: SET<CV> [0..*]ethnic_group_cd: SET<CV> [0..*]
1..1
0..1
R_Party_relationship
class_cd* <= ROL
0..*
0..*
1..1
0..1R_Case_related_party
class_cd* <= ROL
0..*
0..*
0..*P_Observation_participanttype_cd*: CS [1..1] <=PRF+PAT+LOC
1..*
P_Case_participanttype_cd*: <= PAT+LOC+PRF
E_Case_related_organization
class_cd* <= ENTdeterminer_cd* <= INSTANCEcd: CV [0..1]nm: EN [0..1]addr: AD [0..1]
E_Case_related_nonperson_living_subject
class_cd* <= NLIVdeterminer_cd* <= INSTANCEcd: CV [1..1]
E_Case_related_party
E_Specimen
class_cd* <= MATdeterminer_cd*: <= INSTANCEcd*: CV [1..1]
1..1
0..1
R_Specimen_responsibility
class_cd* <= ROL
0..*
0..*
1..1
0..1R_Specimen
class_cd* <= SPEC
0..*
0..*
A_Specimen_collection
class_cd* <= PROCmood_cd*: <= EVNactivity_time: IVL<TS> (0..1)
0..*
P_Specimen
0..*
type_cd*: <= SPC
0..*
P_Specimen_handling
0..*
type_cd*: <= PRF
0..*
AR_Specimen_collectiontype_cd*: <= PERT
A_Associated_notification
class_cd* <= ACTmood_cd*: <= EVNid: II [0..1]cd: CV [1..1]activity_time: IVL<TS> [0..1]
A_Patient_encounter
class_cd* <= ENCmood_cd*: <= EVNactivity_time: IVL<TS> [1..1]
0..*
AR_Associated_notificationtype_cd*: <= PERT
0..*
AR_Patient_encountertype_cd*: <= PERT
A_Public_health_case
class_cd* <= CASEmood_cd*: <= EVNid: II [1..1]cd: CV [1..1]status_cd: CS [0..1]effective_time: IVL<TS> [1..1]activity_time: IVL<TS> [1..1]detection_method_cd: CV [0..1]transmission_mode_cd: CV [0..1]disease_imported_cd: CV [0..1]
Drug Reaction Notification 2 October 2002 - Page: 19SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Comments on the “Payload”Comments on the “Payload”
The original design was based on the current NETSS system.
It only reluctantly added data concepts that were not supported there.
Glaring deficiencies are already clear.Insufficient data for personsOnly observations are linked to the caseDoes not address materials, e.g., vaccines.Insufficient information on specimens.
The original design was based on the current NETSS system.
It only reluctantly added data concepts that were not supported there.
Glaring deficiencies are already clear.Insufficient data for personsOnly observations are linked to the caseDoes not address materials, e.g., vaccines.Insufficient information on specimens.
Drug Reaction Notification 2 October 2002 - Page: 20SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Downstream ArtifactsDownstream Artifacts
Hierarchical Message DescriptionXML SchemasNotification Messaging
DocumentationImplementation Guides (Disease
Specific)Database/Message MappingMessaging Subsystem
Hierarchical Message DescriptionXML SchemasNotification Messaging
DocumentationImplementation Guides (Disease
Specific)Database/Message MappingMessaging Subsystem
Drug Reaction Notification 2 October 2002 - Page: 21SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Working on FDA MessagingWorking on FDA Messaging
Initial Premise – We can use the Notification Messages.Note, this will require enhancement to what is
there today.
First Step – Review the E2BM specifications, and recast in HL7 terms.This was done by mapping the data to the RIM.
Second Step – Determine additional requirements for the Notification Message specification. I have an initial cut at these.
Initial Premise – We can use the Notification Messages.Note, this will require enhancement to what is
there today.
First Step – Review the E2BM specifications, and recast in HL7 terms.This was done by mapping the data to the RIM.
Second Step – Determine additional requirements for the Notification Message specification. I have an initial cut at these.
Drug Reaction Notification 2 October 2002 - Page: 22SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Produced so FarProduced so Far
High level outline of the E2BM transaction.
Diagrammatic mapping of the specification.
Excel spreadsheet containing the mapping details.
List of proposed updates to the Notification R-MIM
High level outline of the E2BM transaction.
Diagrammatic mapping of the specification.
Excel spreadsheet containing the mapping details.
List of proposed updates to the Notification R-MIM
Drug Reaction Notification 2 October 2002 - Page: 23SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Drug Incident NotificationDrug Incident Notification
A_Event_report
class_cd* <= OBSmood_cd* <= EVENTLots of data
A_Reaction
class_cd* <= OBSmood_cd* <= EVENTLots of data
A_Administration
class_cd* <= OBSmood_cd* <= EVENTLots of data
1..*
type_cd* <= COMP
AR_Safety_report
1..*
1..*
type_cd* <= CAUS
AR_Associated*
1..1
R_Patient
class_cd* <= PAT
*
E_Patient
class_cd* <= PSNdeterminer_cd* <= INSTANCELots of data
1..1
P_Patient*type_cd* <= PAT
0..1
P_Parent_subj*type_cd* <= PAT
1..1R_Parent
class_cd* <= PAT
*
E_Parent
class_cd* <= PSNdeterminer_cd* <= INSTANCELots of data 1..1
R_Child
class_cd* <= CHILD
0..1
*
*
0..1
P_Subject*type_cd* <= PAT
1..*
type_cd* <= COMP
AR_Safety_report
1..1
P_Reporting*type_cd* <= PAT
1..1
R_Reporting_Party
class_cd* <= PAT
*
E_Reporting_Party
class_cd* <= PSNdeterminer_cd* <= INSTANCELots of data
Drug Reaction Notification 2 October 2002 - Page: 24SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
E2BM MappingE2BM Mapping
A_Result_of_tests_procedures
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.2 RESULT OF TESTS0..1
type_cd* <= ?
AR_Test_result
1..1
type_cd* <= SPRT
AR_Addl_doc
A_Most_recent
class_cd* <= OBSmood_cd* <= EVENTactivity_time: A.1.7 DATE OF MOST RECENT RECEIPT1..1
type_cd* <= PREV
AR_Recent_report
1..1
type_cd* <= PERT
AR_Seriousness
0..* 0..*
type_cd* <= ?
AR_Indication
A_Reaction_or_event
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i.3 TERM HIGHLIGHTED BY REPORTERactivity_time: B.2.i.4 DATE OF START B.2.i.5 DATE OF END B.2.i.6 DURATION OF REACTIONtxt: B.2.i.0 REACTION AS REPORTED
1..1
type_cd* <= ?
AR_Lowest_level
1..1
type_cd* <= ?
AR_Preferred
0..1
type_cd* <= ?
AR_Initial_dose
0..1
type_cd* <= ?
AR_Last_dose
A_Lowest_level_term
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i.1 MEDRA LOWEST LEVEL
A_Preferred_term
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i2 MEDRA PREFERRED
A_First_dose_interval
class_cd* <= OBSmood_cd* <= EVENTvalue: B.2.i.7.1 BEGINNING TIME INTERVAL
A_Last_dose_interval
class_cd* <= OBSmood_cd* <= EVENTvalue: B.2.i.7.2 LAST DOSE TIME INTERVAL
1..1
type_cd* <= ?
AR_Outcome
A_Outcome
class_cd* <= OBSmood_cd* <= EVENTvalue: B.2.i.8 OUTCOME OF REACTION
A_Relevant_result
class_cd* <= OBSmood_cd* <= EVENTcd: B.3.1b TESTactivity_time: B.3.1a DATEvalue: B.3.1c RESULT B.3.1d UNIT OF MEASURE
1..*
type_cd* <= ?
AR_Normal_range*
A_Observation_normal_range
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.1e NORMAL LOW RANGE B.3.1f NORMAL HIGH RANGEinterpretation_cd
1..1
type_cd* <= ?
AR_Additional_result A_Additional_result
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.1g MORE INFORMATION Y/N
A_Direct_Administration
class_cd* <= SBADMmood_cd* <= EVENTactivity_time: B.4.k.3 NUMBER OF DOSAGES B.4.k.4 NUMBER OF UNITS IN INTERVAL B.4.k.5 DEFINITION OF INTERVAL UNIT B.4.k.12 DATE OF START OF DRUG B.4.k.14 DATE OF LAST ADMINISTRATION B.4.k.15 DURATION OF ADMINISTRATIONdose_qty: B.4.k.5.1 DOSE NUMBER B.4.k.5.2 DOSE UNITtxt: B.4.k.19 ADDITIONAL INFORMATION ON DRUG
0..* 0..*
type_cd* <= ?
AR_CharacterizationA_Drug_role
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.1 DRUG CHARACTERIZATION CODE
1..1
P_Administer_producttype_cd* <= CSM
1..1
0..1R_Content
class_cd* <= ROL
0..*
0..*
E_Therapeutic_product
class_cd* <= MMATdeterminer_cd* <= INSTANCEcd: B.4.k.2.1 MEDICINAL PRODUCT NAMElot_num: B.4.k.3 BATCH OR LOT NUMBERform:cd: B.4.k.7 PHARMACEUTICAL FORM
1..1
0..1R_Ingredient
class_cd* <= ROL
0..*
0..*
E_Therapeutic_product_ingredient
class_cd* <= MMATdeterminer_cd* <= INSTANCEcd: b.4.K.2.2 ACTIVE SUBSTANCE NAME
1..1
0..1 R_Sourced
class_cd* <= ROL
0..*
0..*
E_Country
class_cd* <= PLCdeterminer_cd* <= INSTANCEnm: B.4.k.2.3 ID OF COUNTRY
1..1
0..1
R_Authorization_holder
class_cd* <= ROL
0..*
0..*id: B.4.K.4.1 AUTHORIZATION NUMBER
E_Holder
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: B.4.k.4.3 NAME OF HOLDER
E_Country_of_authorization
class_cd* <= PLCdeterminer_cd* <= INSTANCEnm: B.4.k.4.2 COUNTRY OF AUTHORIZATION
1..1
P_Authorizationtype_cd* <= ?
0..* 0..*
type_cd* <= ?
AR_Cummulative
A_Cummulative_dose
class_cd* <= SBADMmood_cd* <= EVENTdose_qty: B.4.k.5.6 CUMM DOSE TO FIRST REACTION B.4.k.5.7 CUMM DOSE UNIT
A_Indication
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.11 INDICATION FOR USE
1..1
type_cd* <= ?
AR_Local_criteriaA_Local_seriousness_criteria
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.9 CASE FULLFILLS CRITERIA
1..1
type_cd* <= PERT
AR_Additional_case_idsA_Case_id
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.11 OTHER CASE ID
A_Report_nullification
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.13 REPORT NULLIFICATIONtxt: A.1.13.1 REASON FOR NULLIFICATION
A_Medical_Confirmation
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.14 CASE MEDICALLY CONFIRMED
1..1
type_cd* <= ?
AR_Nullification
1..1
type_cd* <= ?
AR_Confirmation
A_Linked_case
class_cd* <= OBSmood_cd* <= EVENTid: A.1.11.2 CASE ID
0..*
type_cd* <= ?
AR_Linked_case
1..*
P_Primary_sourcetype_cd* <= ?1..1
0..1R_Reporter
class_cd* <= ROL
0..*
0..*
cd: A.2.1.4 QUALIFICATION CODEaddr: A.1.2.1.2 REPORTER ADDRESS A.1.2.1.3 REPORTER COUNTRY
E_Reporter
class_cd* <= PSNdeterminer_cd* <= INSTANCEnm: A.2.1.1 REPORTER IDENTIFIER
0..*
type_cd* <= ?
AR_Reference A_Literature_reference
class_cd* <= OBSmood_cd* <= EVENTtxt: A.2.2 LITERATURE REFERENCE
0..1
type_cd* <= ?
AR_Study A_Study
class_cd* <= OBSmood_cd* <= EVENTid: A.2.3.2 SPONSOR STUDY NUMBERcd: A.2.3.3 STUDY TYPEtxt: A.2.3.1 STUDY NAME
0..*
P_Sender
0..*
type_cd* <= AUT
1..1
0..1 R_Report_Sender
class_cd* <= ROL
0..*
0..*
cd: A.3.1.1 TYPEaddr: A.3.1.4 ADDRESStelecom: A.3.1.4 ADDRESS
E_Report_sender
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.1.2 IDENTIFIER
E_Responsible_Person
class_cd* <= ENTdeterminer_cd* <= INSTANCEnm: A.3.1.3 PERSON RESPONSIBLE
0..*
P_Receiver
0..*
type_cd* <= ?1..1
0..1R_Report_Receiver
class_cd* <= ROL
0..*
0..*
cd: A.3.2.1 TYPEaddr: A.3.2.3 ADDRESStelecom: A.3.2.3 ADDRESS
E_Report_receiver
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.2.2 IDENTIFIER
1..1
P_Patienttype_cd* <= ?
1..1
0..1
R_Patient
class_cd* <= ROL
0..*
0..*
id: B.1.1.1 MEDICAL RECORD NUM
E_Patient
class_cd* <= PSNdeterminer_cd* <= INSTANCE
0..*
P_Related_observation
0..*
type_cd* <= ?
A_Patient_characteristic
class_cd* <= OBSmood_cd* <= EVENTactivity_time: B .1.9.1 DATE OF DEATHvalue: B.1.2.1 DATE OF BIRTH B.1.2.2 AGE AT TIME OF ONSET B.1.2.2.1 GESTATION PERIOD OF FETUS B.1.2.3 AGE GROUP CODE B.1.3. WEIGHT B.1.4 HEIGHT B.1.5 SEX B.1.6 LAST MENSTRUAL PERIOD DATE B.1.9.2 REPORTED CAUSE OF DEATH B.1.9.3 PRESENCE OF AUTOPSY B.1.9.4 AUTOPSY DETERMINED CAUSE OF DEATH
A_Indication
class_cd* <= OBSmood_cd* <= ?value: B.1.8 INDICATION A_Reaction
class_cd* <= ACTmood_cd* <= ?value: B.1.8 REACTION
1..1
0..1
R_Child
class_cd* <= ROL
0..*
0..*
E_Parent
class_cd* <= PSNdeterminer_cd* <= INSTANCEnm: B.1.10.1 PARENT IDENTIFICATION
0..*
P_Parent_related_observation
0..*
type_cd* <= ?
A_Parent_characteristic
class_cd* <= OBSmood_cd* <= EVENTvalue: B.1.10.2.1 DATE OF BIRTH B.1.10.2.2 AGE AT TIME OF ONSET B.1.10.3 LAST MENSTRUAL PERIOD DATE B.1.10.4 WEIGHT B.1.10.5 HEIGHT B.1.10.6 SEX
0..*
type_cd* <= ?
AR_Indication
0..*
type_cd* <= ?
AR_Reaction
A_Direct_route
class_cd* <= SBADMmood_cd* <= EVENTroute_cd: B.4.k.8 ROUTE OF ADMINISTRATION
A_Proximate_route
class_cd* <= SBADMmood_cd* <= EVENTroute_cd: B.4.k.9 PARENT ROUTE OF ADMINISTRATION
0..*0..*
type_cd* <= ?
AR_Routing_Option
A_Proximate_administration
class_cd* <= SBADMmood_cd* <= EVENT
0..*0..*
type_cd* <= ?
AR_Routing_Option
A_Case_safety_report
class_cd* <= OBSmood_cd* <= EVENTcd: TYPE OF REPORTid: A.1.0.1 SAFETY REPORT ID A.1.10.1 REG AUTH CASE ID A..1.10.2 SENDER CASE ID A.1.11.1 CASE ID SOURCE A.1.11.2 CASE IDactivity_time: DATE OF TRANSMISSION
1..1
P_Report_sourcetype_cd* <= ?1..1
0..1R_Source_country
class_cd* <= ROL
0..*
0..*
cd:id: A.1.1 PRIMARY COUNTRY ID
1..1
P_Event_loctype_cd* <= ?1..1
0..1R_Event_country
class_cd* <= ROL
0..*
0..*
cd:id: A.1.2 COUNTRY OF EVENT ID
A_Serious_indication
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.5.1 SERIOUS
0..*
type_cd* <= EXPL
AR_Criteria
A_Criteria
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.5.2 SERIOUSNESS CRITERIA
1..1
type_cd* <= PERT
AR_Source_reportA_First_notification
class_cd* <= OBSmood_cd* <= EVENTactivity_time: A.1.6 DATE OF FIRST REPORT
A_Additional_document
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.8.1 ADDITIONAL DOC 0..*
type_cd* <= EXPL
AR_DocumentsA_Document_list
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.8.2 DOCUMENT HELD
0..*0..*
type_cd* <= ?
AR_Parental_Contact
A_Relevant_medical_history
class_cd* <= OBSmood_cd* <= EVENTcd: B.1.7.1 DISEASE/PROCEDURE/ETCactivity_time: B.1.7.1 START DATE, END DATE, CONTINUINGtxt: B.1.7.1 COMMENTvalue: B.1.7.2 TEXT FOR RELEVANT MEDICAL HISTORY
A_Relevant_drug_history
class_cd* <= OBSmood_cd* <= EVENTcd: = B.1.8 NAME OF DRUGactivity_time: B.1.7.1 START DATE, END DATE, CONTINUING B.1.8 START DATE, END DATE
A_Parent_reaction
class_cd* <= ACTmood_cd* <= ?value: B.1.10.8 REACTION A_Parent_indication
class_cd* <= OBSmood_cd* <= ?value: B.1.10.8 INDICATION
A_Parent_medical_history
class_cd* <= OBSmood_cd* <= EVENTcd: B.1.10.7.1 DISEASE/PROCEDURE/ETCactivity_time: B.1.10.7.1 START DATE, END DATE, CONTINUING txt: B.1.10.7.1 COMMENT value: B.1.10.7.2 TEXT FOR RELEVANT MEDICAL HISTORY
A_Parent_drug_history
class_cd* <= OBSmood_cd* <= EVENTcd: B.1.10.8 NAME OF DRUGactivity_time: B.1.10.8 START DATE, END DATE value:
0..*
type_cd* <= ?
AR_Reaction
0..*
type_cd* <= ?
AR_Indication
0..*
P_Related_observation
0..*
type_cd* <= ?
0..*
P_Related_observation
0..*
type_cd* <= ?
0..*
P_Parent_related_observation
0..*
type_cd* <= ?
0..*
P_Parent_related_observation
0..*
type_cd* <= ?
1..1
0..1
R_Parent_patient
class_cd* <= ROL
0..*
0..*
0..1
type_cd* <= ?
AR_Relevant_result
0..* 0..*
type_cd* <= ?
AR_Gestation
A_Gestation_period
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.10 GESTATION PERIOD AT TIME OF EXPOSURE
0..1
type_cd* <= ?
AR_Initial_dose
0..1
type_cd* <= ?
AR_Last_dose
A_Beginning_interval
class_cd* <= OBSmood_cd* <= EVENTvalue: B.4.k.13.1 TIME INTERVAL BETWEEN BEGINNING OF DRUG ADMIN AND REACTION
A_Ending_interval
class_cd* <= OBSmood_cd* <= EVENTvalue:B.4.k.13.2 TIME INTERVAL BETWEEN END OF DRUG ADMIN AND REACTION
0..* 0..*
type_cd* <= ?
AR_Action_taken A_Action_taken
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.16 ACTION TAKEN WITH DRUG
1..1
type_cd* <= SPRT
AR_Rechallenge_reactionA_Rechallenge
class_cd* <= OBSmood_cd* <= EVENTvalue: B.4.k.17.1 REACTION Y/N
0..*
type_cd* <= EXPL
AR_Reaction
A_Rechallenge_reaction
class_cd* <= OBSmood_cd* <= EVENTvalue: B.4.k.17.2 REACTION OR EVENT
A_Reaction_Assessment
class_cd* <= OBSmood_cd* <= EVENTmethod_cd: B.4.k.18.3 METHOD OF ASSESSMENTvalue: B.4.K.18.4 RESULT 0..* 0..*
type_cd* <= ?sequence_nbr:
AR_Associated_reaction
0..*
0..*type_cd* <= ?
AR_Assoicated_administration
0..*
P_Assessor
0..*
type_cd* <= ?
1..1
0..1R_Assessor
class_cd* <= ROL
0..*
0..*
cd: B.4.k.18.2 SOURCE OF ASSESSMENT
A_Case_narrative
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.1 CASE NARRATIVE
1..1
type_cd* <= ?
AR_Associated_narrative
A_Reporter_comment
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.2 REPORTER’S COMMENTS
1..1
type_cd* <= ?
AR_Reporter_comment
A_Sender_comment
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.4 SENDER COMMENT
1..1
type_cd* <= ?
AR_Sender_comment
A_Sender_diagnosis
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.3 SENDER DIAGNOSIS
1..1
type_cd* <= ?
AR_Sender_diagnosis
1..*
type_cd* <= ?
AR_Case
Drug Reaction Notification 2 October 2002 - Page: 25SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Two Forms of MappingTwo Forms of Mapping
0..*
P_Sender
0..*
type_cd* <= AUT
1..1
0..1 R_Report_Sender
class_cd* <= ROL
0..*
0..*
cd: A.3.1.1 TYPEaddr: A.3.1.4 ADDRESStelecom: A.3.1.4 ADDRESS
E_Report_sender
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.1.2 IDENTIFIER
E_Responsible_Person
class_cd* <= ENTdeterminer_cd* <= INSTANCEnm: A.3.1.3 PERSON RESPONSIBLE
0..*
P_Receiver
0..*
type_cd* <= ?
1..1
0..1R_Report_Receiver
class_cd* <= ROL
0..*
0..*
cd: A.3.2.1 TYPEaddr: A.3.2.3 ADDRESStelecom: A.3.2.3 ADDRESS
E_Report_receiver
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.2.2 IDENTIFIER
A_Case_safety_report
class_cd* <= OBSmood_cd* <= EVENTcd: TYPE OF REPORTid: A.1.0.1 SAFETY REPORT ID A.1.10.1 REG AUTH CASE ID A..1.10.2 SENDER CASE ID A.1.11.1 CASE ID SOURCE A.1.11.2 CASE IDactivity_time: DATE OF TRANSMISSION
0..*
P_Sender
0..*
type_cd* <= AUT
1..1
0..1 R_Report_Sender
class_cd* <= ROL
0..*
0..*
cd: A.3.1.1 TYPEaddr: A.3.1.4 ADDRESStelecom: A.3.1.4 ADDRESS
E_Report_sender
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.1.2 IDENTIFIER
E_Responsible_Person
class_cd* <= ENTdeterminer_cd* <= INSTANCEnm: A.3.1.3 PERSON RESPONSIBLE
0..*
P_Receiver
0..*
type_cd* <= ?
1..1
0..1R_Report_Receiver
class_cd* <= ROL
0..*
0..*
cd: A.3.2.1 TYPEaddr: A.3.2.3 ADDRESStelecom: A.3.2.3 ADDRESS
E_Report_receiver
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.2.2 IDENTIFIER
A_Case_safety_report
class_cd* <= OBSmood_cd* <= EVENTcd: TYPE OF REPORTid: A.1.0.1 SAFETY REPORT ID A.1.10.1 REG AUTH CASE ID A..1.10.2 SENDER CASE ID A.1.11.1 CASE ID SOURCE A.1.11.2 CASE IDactivity_time: DATE OF TRANSMISSION
Drug Reaction Notification 2 October 2002 - Page: 26SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Report Patient & Other PartiesReport Patient & Other Parties
1..*
P_Primary_sourcetype_cd* <= ?1..1
0..1 R_Reporter
class_cd* <= ROL
0..*
0..*
cd: A.2.1.4 QUALIFICATION CODEaddr: A.1.2.1.2 REPORTER ADDRESS A.1.2.1.3 REPORTER COUNTRY
E_Reporter
class_cd* <= PSNdeterminer_cd* <= INSTANCEnm: A.2.1.1 REPORTER IDENTIFIER
0..*
P_Sender
0..*
type_cd* <= AUT
1..1
0..1
R_Report_Sender
class_cd* <= ROL
0..*
0..*
cd: A.3.1.1 TYPEaddr: A.3.1.4 ADDRESStelecom: A.3.1.4 ADDRESS
E_Sender_Organization
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.1.2 IDENTIFIER
E_Responsible_Person
class_cd* <= ENTdeterminer_cd* <= INSTANCEnm: A.3.1.3 PERSON RESPONSIBLE
0..*
P_Receiver
0..*
type_cd* <= ?
1..1
0..1
R_Report_Receiver
class_cd* <= ROL
0..*
0..*
cd: A.3.2.1 TYPEaddr: A.3.2.3 ADDRESStelecom: A.3.2.3 ADDRESS
E_Report_receiver
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: A.3.2.2 IDENTIFIER
1..1
P_Patienttype_cd* <= ?
1..1
0..1
R_Patient
class_cd* <= ROL
0..*
0..*
id: B.1.1.1 MEDICAL RECORD NUM
E_Patient
class_cd* <= PSNdeterminer_cd* <= INSTANCE
0..*
P_Related_observation
0..*
type_cd* <= ?
A_Patient_characteristic
class_cd* <= OBSmood_cd* <= EVENTactivity_time: B .1.9.1 DATE OF DEATHvalue: B.1.2.1 DATE OF BIRTH B.1.2.2 AGE AT TIME OF ONSET B.1.2.2.1 GESTATION PERIOD OF FETUS B.1.2.3 AGE GROUP CODE B.1.3. WEIGHT B.1.4 HEIGHT B.1.5 SEX B.1.6 LAST MENSTRUAL PERIOD DATE B.1.9.2 REPORTED CAUSE OF DEATH B.1.9.3 PRESENCE OF AUTOPSY B.1.9.4 AUTOPSY DETERMINED CAUSE OF DEATH
A_Indication
class_cd* <= OBSmood_cd* <= ?value: B.1.8 INDICATION
A_Reaction
class_cd* <= ACTmood_cd* <= ?value: B.1.8 REACTION
1..1
0..1
R_Child
class_cd* <= ROL
0..*
0..*
E_Parent
class_cd* <= PSNdeterminer_cd* <= INSTANCEnm: B.1.10.1 PARENT IDENTIFICATION
0..*
P_Parent_related_observation
0..*
type_cd* <= ?
A_Parent_characteristic
class_cd* <= OBSmood_cd* <= EVENTvalue: B.1.10.2.1 DATE OF BIRTH B.1.10.2.2 AGE AT TIME OF ONSET B.1.10.3 LAST MENSTRUAL PERIOD DATE B.1.10.4 WEIGHT B.1.10.5 HEIGHT B.1.10.6 SEX
0..*
type_cd* <= ?
AR_Indication
0..*
type_cd* <= ?
AR_Reaction
1..1
P_Report_sourcetype_cd* <= ?1..1
0..1R_Source_country
class_cd* <= ROL
0..*
0..*
cd:id: A.1.1 PRIMARY COUNTRY ID
A_Relevant_medical_history
class_cd* <= OBSmood_cd* <= EVENTcd: B.1.7.1 DISEASE/PROCEDURE/ETCactivity_time: B.1.7.1 START DATE, END DATE, CONTINUINGtxt: B.1.7.1 COMMENTvalue: B.1.7.2 TEXT FOR RELEVANT MEDICAL HISTORY
A_Relevant_drug_history
class_cd* <= OBSmood_cd* <= EVENTcd: = FDA064 Relevant Drug Historyactivity_time: B.1.7.1 START DATE, END DATE, CONTINUING B.1.8 START DATE, END DATEtxt: B.1.8 NAME OF DRUG
A_Parent_reaction
class_cd* <= ACTmood_cd* <= ?value: B.1.10.8 REACTION
A_Parent_indication
class_cd* <= OBSmood_cd* <= ?value: B.1.10.8 INDICATION
A_Parent_medical_history
class_cd* <= OBSmood_cd* <= EVENTcd: B.1.10.7.1 DISEASE/PROCEDURE/ETCactivity_time: B.1.10.7.1 START DATE, END DATE, CONTINUING txt: B.1.10.7.1 COMMENT value: B.1.10.7.2 TEXT FOR RELEVANT MEDICAL HISTORY
A_Parent_drug_history
class_cd* <= OBSmood_cd* <= EVENTcd: FDA065 Parent Drug Historyactivity_time: B.1.10.8 START DATE, END DATEtxt: B.1.10.8 NAME OF DRUG
0..*
type_cd* <= ?
AR_Reaction
0..*
type_cd* <= ?
AR_Indication
0..*
P_Related_observation
0..*
type_cd* <= ?
0..*
P_Related_observation
0..*
type_cd* <= ?
0..*
P_Parent_related_observation
0..*
type_cd* <= ?
0..*
P_Parent_related_observation
0..*
type_cd* <= ?
1..1 0..1
R_Parent_patient
class_cd* <= ROL
0..*
0..*
A_Case_safety_report
class_cd* <= OBSmood_cd* <= EVENTcd: TYPE OF REPORTid: A.1.0.1 SAFETY REPORT ID A.1.10.1 REG AUTH CASE ID A..1.10.2 SENDER CASE ID A.1.11.1 CASE ID SOURCE A.1.11.2 CASE IDactivity_time: DATE OF TRANSMISSION
E_Reporter_Department
class_cd* = ORGdeterminer_cd* <= INSTANCEnm: A.2.1.2 REPORTER ADDRESS
E_Reporter_Organization
class_cd* = ORGdeterminer_cd* <= INSTANCEnm: A.2.1.2 REPORTER ADDRESS
1..1
0..1
R_Reporter_Department
class_cd* <= ROL
0..*
0..*
E_Sender_Department
class_cd* = ORGdeterminer_cd* <= INSTANCEnm: A.3.1.3 PERSON RESPONSIBLE
1..1
0..1R_Sender_Department
class_cd* <= ROL
0..*
0..*
E_Receiver_Department
class_cd* = ORGdeterminer_cd* <= INSTANCEnm: A.3.2.2 IDENTIFIER
1..1
0..1 R_Receiver_Department
class_cd* <= ROL
0..*
0..*
E_Receiver_Organization
class_cd* = ORGdeterminer_cd* <= INSTANCEnm: A.3.2.2 IDENTIFIER
A_Continuing
class_cd* <= ACTmood_cd* <= ?value: B.1.7.1 CONTINUING
0..*
type_cd* <= ?
AR_CONTINUATION
Drug Reaction Notification 2 October 2002 - Page: 27SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Case Safety Report DetailsCase Safety Report Details
A_Result_of_tests_procedures
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.2 RESULT OF TESTS
0..1
type_cd* <= ?
AR_Test_result
1..1
type_cd* <= SPRT
AR_Addl_doc
A_Most_recent
class_cd* <= OBSmood_cd* <= EVENTactivity_time: A.1.7 DATE OF MOST RECENT RECEIPT1..1
type_cd* <= PREV
AR_Recent_report
1..1
type_cd* <= PERT
AR_Seriousness
A_Relevant_result
class_cd* <= OBSmood_cd* <= EVENTcd: B.3.1b TESTactivity_time: B.3.1a DATEvalue: B.3.1c RESULT B.3.1d UNIT OF MEASURE
1..*
type_cd* <= ?
AR_Normal_range*
A_Observation_normal_range
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.1e NORMAL LOW RANGE B.3.1f NORMAL HIGH RANGEinterpretation_cd
1..1
type_cd* <= ?
AR_Additional_result
A_Additional_result
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.1g MORE INFORMATION Y/N
1..1
type_cd* <= ?
AR_Local_criteriaA_Local_seriousness_criteria
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.9 CASE FULLFILLS CRITERIA
1..1
type_cd* <= PERT
AR_Additional_case_idsA_Case_id
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.11 OTHER CASE ID
A_Report_nullification
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.13 REPORT NULLIFICATIONtxt: A.1.13.1 REASON FOR NULLIFICATION
A_Medical_Confirmation
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.14 CASE MEDICALLY CONFIRMED
1..1
type_cd* <= ?
AR_Nullification
1..1
type_cd* <= ?
AR_Confirmation
A_Linked_case
class_cd* <= OBSmood_cd* <= EVENTid: A.1.11.2 CASE ID
0..*
type_cd* <= ?
AR_Linked_case
0..*
type_cd* <= ?
AR_Reference
A_Literature_reference
class_cd* <= OBSmood_cd* <= EVENTtxt: A.2.2 LITERATURE REFERENCE
0..1
type_cd* <= ?
AR_StudyA_Study
class_cd* <= OBSmood_cd* <= EVENTid: A.2.3.2 SPONSOR STUDY NUMBERcd: A.2.3.3 STUDY TYPEtxt: A.2.3.1 STUDY NAME
A_Case_safety_report
class_cd* <= OBSmood_cd* <= EVENTcd: TYPE OF REPORTid: A.1.0.1 SAFETY REPORT ID A.1.10.1 REG AUTH CASE ID A..1.10.2 SENDER CASE ID A.1.11.1 CASE ID SOURCE A.1.11.2 CASE IDactivity_time: DATE OF TRANSMISSION
A_Serious_indication
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.5.1 SERIOUS 0..*
type_cd* <= EXPL
AR_Criteria
A_Criteria
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.5.2 SERIOUSNESS CRITERIA
1..1
type_cd* <= PERT
AR_Source_reportA_First_notification
class_cd* <= OBSmood_cd* <= EVENTactivity_time: A.1.6 DATE OF FIRST REPORT
A_Additional_document
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.8.1 ADDITIONAL DOC 0..*
type_cd* <= EXPL
AR_Documents
A_Document_list
class_cd* <= OBSmood_cd* <= EVENTvalue: A.1.8.2 DOCUMENT HELD
0..1
type_cd* <= ?
AR_Relevant_result
A_Case_narrative
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.1 CASE NARRATIVE 1..1
type_cd* <= ?
AR_Associated_narrative
A_Reporter_comment
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.2 REPORTER’S COMMENTS 1..1
type_cd* <= ?
AR_Reporter_comment
A_Sender_comment
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.4 SENDER COMMENT
1..1
type_cd* <= ?
AR_Sender_comment
A_Sender_diagnosis
class_cd* <= OBSmood_cd* <= EVENTvalue: B.5.3 SENDER DIAGNOSIS
1..1
type_cd* <= ?
AR_Sender_diagnosis
A_Test_Measurements
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.3.2 RESULT OF TESTS
1..1
type_cd* <= ?
AR_Measurements
Drug Reaction Notification 2 October 2002 - Page: 28SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Drug ReactionDrug Reaction
A_Reaction_or_event
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i.3 TERM HIGHLIGHTED BY REPORTERactivity_time: B.2.i.4 DATE OF START B.2.i.5 DATE OF END B.2.i.6 DURATION OF REACTIONtxt: B.2.i.0 REACTION AS REPORTED
1..1
type_cd* <= ?
AR_Lowest_level
1..1
type_cd* <= ?
AR_Preferred
0..1
type_cd* <= ?
AR_Initial_dose
0..1
type_cd* <= ?
AR_Last_dose
A_Lowest_level_term
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i.1 MEDRA LOWEST LEVEL
A_Preferred_term
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i2 MEDRA PREFERRED
A_First_dose_interval
class_cd* <= OBSmood_cd* <= EVENTvalue: B.2.i.7.1 BEGINNING TIME INTERVAL
A_Last_dose_interval
class_cd* <= OBSmood_cd* <= EVENTvalue: B.2.i.7.2 LAST DOSE TIME INTERVAL
1..1
type_cd* <= ?
AR_OutcomeA_Outcome
class_cd* <= OBSmood_cd* <= EVENTvalue: B.2.i.8 OUTCOME OF REACTION
1..1
P_Event_loctype_cd* <= ?
1..1
0..1R_Event_country
class_cd* <= ROL
0..*
0..*
cd:id: A.1.2 COUNTRY OF EVENT ID
1..*
type_cd* <= ?
AR_Case
A_Case_safety_report
class_cd* <= OBSmood_cd* <= EVENTcd: TYPE OF REPORTid: A.1.0.1 SAFETY REPORT ID A.1.10.1 REG AUTH CASE ID A..1.10.2 SENDER CASE ID A.1.11.1 CASE ID SOURCE A.1.11.2 CASE IDactivity_time: DATE OF TRANSMISSION
Drug Reaction Notification 2 October 2002 - Page: 29SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Associated AdministrationAssociated Administration
0..* 0..*
type_cd* <= ?
AR_Indication
A_Direct_Administration
class_cd* <= SBADMmood_cd* <= EVENTactivity_time: B.4.k.3 NUMBER OF DOSAGES B.4.k.4 NUMBER OF UNITS IN INTERVAL B.4.k.5 DEFINITION OF INTERVAL UNIT B.4.k.12 DATE OF START OF DRUG B.4.k.14 DATE OF LAST ADMINISTRATION B.4.k.15 DURATION OF ADMINISTRATIONid: B.4.K.4.1 AUTHORIZATION NUMBERdose_qty: B.4.k.5.1 DOSE NUMBER B.4.k.5.2 DOSE UNITtxt: B.4.k.19 ADDITIONAL INFORMATION ON DRUG
0..* 0..*
type_cd* <= ?
AR_Characterization
A_Drug_role
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.1 DRUG CHARACTERIZATION CODE
1..1
P_Administer_producttype_cd* <= CSM
1..1
0..1R_Content
class_cd* <= ROL
0..*
0..*
E_Therapeutic_product
class_cd* <= MMATdeterminer_cd* <= INSTANCEcd: B.4.k.2.1 MEDICINAL PRODUCT NAMElot_num: B.4.k.3 BATCH OR LOT NUMBERform:cd: B.4.k.7 PHARMACEUTICAL FORM
1..1
0..1R_Ingredient
class_cd* <= ROL
0..*
0..*
E_Therapeutic_product_ingredient
class_cd* <= MMATdeterminer_cd* <= INSTANCEcd: b.4.K.2.2 ACTIVE SUBSTANCE NAME
1..1
0..1 R_Sourced
class_cd* <= ROL
0..*
0..*
E_Country
class_cd* <= PLCdeterminer_cd* <= INSTANCEnm: B.4.k.2.3 ID OF COUNTRY
1..1
0..1
R_Authorization_holder
class_cd* <= ROL
0..*
0..*
E_Holder
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: B.4.k.4.3 NAME OF HOLDER
E_Country_of_authorization
class_cd* <= PLCdeterminer_cd* <= INSTANCEnm: B.4.k.4.2 COUNTRY OF AUTHORIZATION
1..1
P_Authorizationtype_cd* <= ?
0..* 0..*
type_cd* <= ?
AR_Cummulative
A_Cummulative_dose
class_cd* <= SBADMmood_cd* <= EVENTdose_qty: B.4.k.5.6 CUMM DOSE TO FIRST REACTION B.4.k.5.7 CUMM DOSE UNIT
A_Indication
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.11 INDICATION FOR USE
A_Direct_route
class_cd* <= SBADMmood_cd* <= EVENTroute_cd: B.4.k.8 ROUTE OF ADMINISTRATION
A_Proximate_route
class_cd* <= SBADMmood_cd* <= EVENTroute_cd: B.4.k.9 PARENT ROUTE OF ADMINISTRATION
0..*0..*
type_cd* <= ?
AR_Routing_Option
A_Proximate_administration
class_cd* <= SBADMmood_cd* <= EVENT
0..*0..*
type_cd* <= ?
AR_Routing_Option0..*0..*
type_cd* <= ?
AR_Parental_Contact
0..* 0..*
type_cd* <= ?
AR_Gestation
A_Gestation_period
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.10 GESTATION PERIOD AT TIME OF EXPOSURE
0..1
type_cd* <= ?
AR_Initial_dose
0..1
type_cd* <= ?
AR_Last_dose
A_Beginning_interval
class_cd* <= OBSmood_cd* <= EVENTvalue: B.4.k.13.1 TIME INTERVAL BETWEEN BEGINNING OF DRUG ADMIN AND REACTION
A_Ending_interval
class_cd* <= OBSmood_cd* <= EVENTvalue:B.4.k.13.2 TIME INTERVAL BETWEEN END OF DRUG ADMIN AND REACTION
0..* 0..*
type_cd* <= ?
AR_Action_taken
A_Action_taken
class_cd* <= OBSmood_cd* <= EVENTcd:value: B.4.k.16 ACTION TAKEN WITH DRUG
1..1
type_cd* <= SPRT
AR_Rechallenge_reactionA_Rechallenge
class_cd* <= OBSmood_cd* <= EVENTvalue: B.4.k.17.1 REACTION Y/N
0..*
type_cd* <= EXPL
AR_Reaction
A_Rechallenge_reaction
class_cd* <= OBSmood_cd* <= EVENTvalue: B.4.k.17.2 REACTION OR EVENT
A_Reaction_Assessment
class_cd* <= OBSmood_cd* <= EVENTmethod_cd: B.4.k.18.3 METHOD OF ASSESSMENTvalue: B.4.K.18.4 RESULT
0..*
0..*
type_cd* <= ?sequence_nbr:
AR_Associated_reaction
0..*
0..*type_cd* <= ?
AR_Associated_administration
0..*
P_Assessor
0..*
type_cd* <= ?1..10..1
R_Assessor
class_cd* <= ROL
0..*
0..*
cd: B.4.k.18.2 SOURCE OF ASSESSMENT
A_Reaction_or_event
class_cd* <= OBSmood_cd* <= EVENTcd: B.2.i.3 TERM HIGHLIGHTED BY REPORTERactivity_time: B.2.i.4 DATE OF START B.2.i.5 DATE OF END B.2.i.6 DURATION OF REACTIONtxt: B.2.i.0 REACTION AS REPORTED
E_Assesor
class_cd* <= ORGdeterminer_cd* <= INSTANCEnm: B.4.k.18.2 SOURCE CODE
Drug Reaction Notification 2 October 2002 - Page: 30SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Proposed Notification Proposed Notification EnhancementsEnhancements Entity identification
Name and multiple identifiers for persons, organizations, and locations. Addresses and phone numbers also. [Supports: drug reaction responses, vaccinations. BT Response contacts.]
Material Information about products – materials – that are used in patient treatment, and in clinical trials. [Supports drug reporting, clinical trials.]
Entity associationRelevant time span associations between parties. [Supports BT Response contacts].
SpecimenSpecimen source, accession number, specimen details. [Supports BT Response and disease surveillance.]
Entity identificationName and multiple identifiers for persons, organizations, and locations. Addresses and phone numbers also. [Supports: drug reaction responses, vaccinations. BT Response contacts.]
Material Information about products – materials – that are used in patient treatment, and in clinical trials. [Supports drug reporting, clinical trials.]
Entity associationRelevant time span associations between parties. [Supports BT Response contacts].
SpecimenSpecimen source, accession number, specimen details. [Supports BT Response and disease surveillance.]
Drug Reaction Notification 2 October 2002 - Page: 31SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
More Notification EnhancementsMore Notification Enhancements Location context for environmental specimens.
Detailed information describing the place where specimens were collected. Includes detailed location information, and managing the association between locations. [Supports BT Response investigations]
Observation informationDescriptive text related to an observation. [Supports Drug incident reporting]
Intervention informationInterventions, e.g., vaccinations, related to a case. [Supports BT Response, enhanced surveillance, drug incident reporting]
Materials informationAdd materials, in particular drugs and vaccines, to the list of entity types that can be related to a case, and to the acts associated with a case. [Supports vaccine preventable disease surveillance, drug reaction reporting.]
Location context for environmental specimens.Detailed information describing the place where specimens were collected. Includes detailed location information, and managing the association between locations. [Supports BT Response investigations]
Observation informationDescriptive text related to an observation. [Supports Drug incident reporting]
Intervention informationInterventions, e.g., vaccinations, related to a case. [Supports BT Response, enhanced surveillance, drug incident reporting]
Materials informationAdd materials, in particular drugs and vaccines, to the list of entity types that can be related to a case, and to the acts associated with a case. [Supports vaccine preventable disease surveillance, drug reaction reporting.]
Drug Reaction Notification 2 October 2002 - Page: 32SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Notification V2 - TodayNotification V2 - TodayPertinentInformationtype_cd*<= PERT0..*
subjectAct
0..* pertinentAct
sequence_nbr: INT [0..1]
0..* pertinentActEventPertinentInformationAtype_cd*<= PERT
0..* pertinentProcedureEvent
PertinentInformationBtype_cd*<= PERT
0..* pertinentEncounterEventPertinentInformationCtype_cd*<= PERT
0..* actComponenttype_cd*<= COMP
0..* act
0..* specimenSpecimentype_cd*<= SPC
0..* act
0..* participantPerformertype_cd*<= PRF
0..* participant
PerformerAtype_cd*<= PRF+PAT+LOCfunction_cd: CV [0..1]time: IVL<TS>
1..* participantPatienttype_cd*<= PAT+LOC+PRF
0..* srcActName
0..* participant
Participanttype_cd*<= ?
0..1player 0..1scoper
Roleclass_cd <= ROL
0..* scopedRole
0..* playedRolecd: CV [0..1]
0..1player
RoleAclass_cd <= ROL
0..* playedRoleB
0..1player
0..1scopingMaterial
RoleBclass_cd <= ROL
0..* scopedRole
0..* playedRoleA
0..1specimenMaterial
0..1source
SpecimenRoleclass_cd <= SPEC
0..* specimen
0..* specimenSource
0..1playingPlace
RoleCclass_cd <= ROL
0..* playedRoleid: II [0..1]cd: CV [1..1]
Place
class_cd* <= PLCdeterminer_cd* <= INSTANCEid: II [0..*]cd: CV [1..1]nm: EN [0..1]addr: AD [0..1]
Person
class_cd* <= PSNdeterminer_cd* <= INSTANCEid: II [0..*]nm: EN [0..1]birth_time: TS [0..1]deceased_ind: BL [0..1]deceased_time: TS [0..1]marital_status_cd: CV [0..1]education_level_cd: CV [0..1]race_cd: SET<CV> [0..*]ethnic_group_cd: SET<CV> [0..*]administrative_sex_cd: CV [0..1]
Material
class_cd* <= MATdeterminer_cd* <= INSTANCEid: II [0..1]cd*: CV [1..1]existence_time: IVL<TS> [0..1]form_cd: CV [0..1]lot_num: ST [0..1]expiration_time: TS [0..1]
Organization
class_cd* <= ORGdeterminer_cd* <= INSTANCEid: II [0..*]cd: CV [0..1]nm: EN [0..1]addr: AD [0..1]
NonPersonLivingSubject
class_cd* <= NLIVdeterminer_cd* <= INSTANCEid: II [0..*]cd: CV [1..1]
PlaceA
class_cd* <= PLCdeterminer_cd* <= INSTANCEcd: CV [0..1]nm: EN [0..1]
EntityChoice
ActChoiceObservationEventclass_cd* <= OBSmood_cd* <= EVNcd: CV [1..1]txt: ST [0..1]effective_time: IVL<TS> [0..1]activity_time: IVL<TS> [0..1]value: ANY [1..1]interpretation_cd: CV [0..1]method_cd: CV [0..1]
ActEventclass_cd* <= ACTmood_cd* <= EVNid: II [0..1]cd: CV [1..1]activity_time: IVL<TS> [0..1]
PublicHealthCaseEventclass_cd* <= CASEmood_cd* <= EVNid: II [1..*]cd: CV [1..1]txt: ST [0..1]status_cd: CS [0..1]effective_time: IVL<TS> [1..1]activity_time: IVL<TS> [1..1]detection_method_cd: CV [0..1]transmission_mode_cd: CV [0..1]disease_imported_cd: CV [0..1]
ProcedureEventclass_cd* <= PROCmood_cd* <= EVNactivity_time: IVL<TS> [0..1]
EncounterEventclass_cd* <= ENCmood_cd* <= EVNactivity_time: IVL<TS> [1..1]
ProcedureEventAclass_cd* <= PROCmood_cd* <= EVNcd: CV [1..1]activity_time: GTS [0..1]target_site_cd: CV [0..1]
SubstanceAdministrationEventclass_cd* <= SBADMmood_cd* <= EVNcd: CV [1..1]txt: ST [0..1]activity_time: GTS [0..1]route_cd: CV [0..1]dose_qty: PQ [0..1]
Case Report(UUDD_RMnnnnnn)
This message is used for thereporting of notifiable diseaseson the part of public health agenciesand BT response teams. It can alsobe used to support FDA drug incidentreporting (E2BM compliant)
Drug Reaction Notification 2 October 2002 - Page: 33SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Later: HL7 Specification ProcessLater: HL7 Specification Process
Start discussions in HL7.Pick the time to move forward with a
proposal.Work out whether a new message
format is needed – I think it will be.Address Committee Issues.Frame a concrete proposal.
Start discussions in HL7.Pick the time to move forward with a
proposal.Work out whether a new message
format is needed – I think it will be.Address Committee Issues.Frame a concrete proposal.
Drug Reaction Notification 2 October 2002 - Page: 34SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Next Steps for UsNext Steps for Us
Verify the detailed mappingThis has been done
Move forward with a standard messageCreate an enhanced Notification MessagePrepare a proposal for HL7 discussionCarry out education within HL7
Start process within FDA to lay out the steps leading towards message implementation.
Verify the detailed mappingThis has been done
Move forward with a standard messageCreate an enhanced Notification MessagePrepare a proposal for HL7 discussionCarry out education within HL7
Start process within FDA to lay out the steps leading towards message implementation.
Drug Reaction Notification 2 October 2002 - Page: 35SAFER – HEALTHIER –
PEOPLE
CDC NEDSS
Any More Questions?Any More Questions?
Mead Walkerhealthcare informatics
consultant
Voice: 610-518-6259Fax: 509-357-7983Email: [email protected]
Mead Walkerhealthcare informatics
consultant
Voice: 610-518-6259Fax: 509-357-7983Email: [email protected]